The Angelina Jolie effect: How high celebrity profile can have a major impact on provision of cancer related services

Breast Cancer Research

Volumn 16, Issue 5, 2014, Pages

  Evans, D G R ^a,b   Barwell, Julian ^c   Eccles, Diana M ^d   Collins, Amanda ^d   Izatt, Louise ^e   Jacobs, Chris ^e   Donaldson, Alan ^f   Brady, Angela F ^g   Cuthbert, Andrew ^h   Harrison, Rachel ⁱ   Thomas, Sue ⁱ   Howell, Anthony ^a   Miedzybrodzka, Zosia ^j,k   Murray, Alex ^l  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c Leicester Genetics Service   (United Kingdom)

^d Regional Genetics Service Coxford Road Southampton   (United Kingdom)

^e GUY S HOSPITAL   (United Kingdom)

^f ST MICHAEL'S HOSPITAL   (United Kingdom)

^g Kennedy Galton Centre   (United Kingdom)

^h BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁱ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^j UNIVERSITY OF ABERDEEN   (United Kingdom)

^k North of Scotland Regional Genetics Service   (United Kingdom)

^l Cardiff   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; TAMOXIFEN;

ARTICLE; AWARENESS; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RELATED SERVICE; CANCER RESEARCH; CANCER SCREENING; CANCER SURGERY; CHEMOPROPHYLAXIS; COLORECTAL CANCER; FAMILY HISTORY; FEMALE; GENERAL PRACTITIONER; GENETIC SCREENING; HUMAN; MASS MEDIUM; MASTECTOMY; MEDICAL SERVICE; NEOPLASM; PATIENT REFERRAL; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PUBLIC FIGURE; RISK REDUCING MASTECTOMY; TUMOR SUPPRESSOR GENE; UNITED KINGDOM; UTERINE CERVIX CANCER; BREAST NEOPLASMS; GENETIC PREDISPOSITION; GENETICS; GREAT BRITAIN; RISK REDUCTION; STATISTICS AND NUMERICAL DATA;

BREAST NEOPLASMS; FAMOUS PERSONS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; MASTECTOMY; REFERRAL AND CONSULTATION; RISK REDUCTION BEHAVIOR;

EID: 84908091789     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0442-6     Document Type: Article

References (21)

1. thebmj News. []., http://www.bmj.com/content/346/bmj.f4116
2. The Boston Globe. []., http://www.bostonglobe.com/lifestyle/health-wellness/2013/12/09/increase-breast-cancer-gene-screening-angelina-jolie-effect/0iwwmG7KqyPUQpHRouD0hN/story.html
3. CBC News. []., http://www.cbc.ca/news/canada/nova-scotia/angelina-jolie-effect-sparks-surge-in-genetic-testing-1.2101587
4. The Sydney Morning Herald. []., http://www.smh.com.au/national/health/breast-cancer-genetic-testing-soars-after-angelina-jolies-double-mastectomy-20131112-2xelm.html
5. New Zealand Doctor. []., http://www.nzherald.co.nz/lifestyle/news/article.cfm?c_id=6&objectid=10891763
6. London Evening Standard. []., http://www.standard.co.uk/news/health/angelina-jolie-effect-has-doubled-hospital-breast-cancer-checks-8659187.html
7. Hereditary Breast Cancer Helpline. .., http://www.breastcancergenetics.co.uk/angelina%20jolie.html
8. Evans DGR, Fentiman IS, McPherson K, Asbury D, Ponder BAJ, Howell A. Familial breast cancer. Brit Med J 1994, 308:183-187. 10.1136/bmj.308.6922.183, 8312772.
9. Evans DGR, Cuzick J, Howell A. Cancer Genetics Clinics. Eur J Cancer 1996, 32:391-392. 10.1016/0959-8049(96)00082-2.
10. Eccles DM, Evans DGR, Mackay J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. J Med Genet 2000, 37:203-209. 10.1136/jmg.37.3.203, 10699057.
11. McIntosh A, Shaw C, Evans G, Turnbull N, Bahar N, Barclay M, Easton D, Emery J, Gray J, Halpin J, Hopwood P, McKay J, Sheppard C, Sibbering M, Watson W, Wailoo A, Hutchinson A. Clinical Guidelines and Evidence Review for The Classification and Care of Women at Risk of Familial Breast Cancer 2004, National Collaborating Centre for Primary Care/University of Sheffield, London.
12. Evans DG, Graham J, O'Connell S, Arnold S, Fitzsimmons D. Familial breast cancer: summary of updated NICE guidance. BMJ 2013, 346:f3829. 10.1136/bmj.f3829, 23801680.
13. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 2010, 11:1127-1134. 10.1016/S1470-2045(10)70263-1.
14. Evans DG, Thomas S, Caunt J, Roberts L, Howell A, Wilson M, Fox R, Sibbering DM, Moss S, Wallis MG, Eccles DM. FH02 study group, Duffy S. Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02). Fam Cancer 2014, 13(1):13-21. 10.1007/s10689-013-9661-8, 23733252.
15. Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med 2013, 16:516-521. 10.1038/gim.2013.181, 24357847.
16. NHS Cervical Cancer Screening Programme. []., http://www.cancerscreening.nhs.uk/cervical/news/020.html
17. Lancucki L, Sasieni P, Patnick J, Day TJ, Vessey MP. The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme. J Med Screen 2012, 19:89-93. 10.1258/jms.2012.012028, 22653575.
18. Marlow LA, Sangha A, Patnick J, Waller J. The Jade Goody Effect: whose cervical screening decisions were influenced by her story?. J Med Screen 2012, 19:184-188. 10.1258/jms.2012.012095, 23271834.
19. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 2003, 163:1601-1605. 10.1001/archinte.163.13.1601, 12860585.
20. Kelaher M, Cawson J, Miller J, Kavanagh A, Dunt D, Studdert DM. Use of breast cancer screening and treatment services by Australian women aged 25-44 years following Kylie Minogue's breast cancer diagnosis. Int J Epidemiol 2005, 37(6):1326-1332. 10.1093/ije/dyn090.
21. Nattinger AB, Hoffmann RG, Howell-Pelz A, Goodwin JS. Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. JAMA 1998, 279:762-766. 10.1001/jama.279.10.762, 9508152.